ARC-omix is built around your workflow. Ordering takes minutes; results arrive with an interpretation guide written for clinicians and patient-facing materials for the visit. Order the ARC-PREVENT panel for proactive profiling, or an ARC test when a specific indication is in front of you.
LDL of 140 and a Pooled Cohort Equations estimate of 8.5% — below the statin threshold. A top-decile ARC-CHD score reclassifies the patient and supports earlier statin consideration.
Father had an MI at 52; no familial hypercholesterolemia variant found; standard workup clean. ARC-CHD further quantifies the heritable load so you can decide whether earlier screening or treatment is warranted.
A motivated 45-year-old with no symptoms. The ARC-PREVENT panel returns percentile and absolute risk across seven conditions, letting you personalize screening intervals and counseling.
01
Sign in to the ARC-omix portal, select the panel or test, and confirm. About five minutes.
02
Saliva kit arrives within two days with a prepaid return label; or provide a requisition for a blood draw at any phlebotomy lab. No visit required.
03
Report delivered to the ordering provider via the secure portal after specimen receipt, with EHR-embedded decision support.
04
The report includes a plain-language summary to hand to the patient and talking-point guidance for each risk tier.
Each report answers the two questions clinicians ask: how high is this patient's risk, and what should I do about it?
Percentile score for each condition
Absolute risk estimate where feasible
Suggested clinical actions at each risk tier
Cascade-testing guidance on monogenic-positive findings
Patient-facing summary suitable to hand over during the visit
References to supporting evidence for each condition
Sample result — fictional patient
Action: Consider statin therapy and refer to cardiology
Action: Check eGFR and urine albumin at next visit
Action: Routine lifestyle counseling
Action: No additional monitoring indicated
ARC-omix combines clinical context with integrated genomic risk that includes validated PRS and rare-variant and family history in one report.
Coverage for clinical PRS testing is currently cash pay.
PRS performance varies by genetic ancestry, a legacy of Euro-centric GWAS training data. ARC-omix addresses this with ensemble scoring and genotype-derived ancestry calibration.
The ARC-PREVENT panel includes PRS for seven conditions. Six ARC tests — ARC-CHD, ARC-CHOL, ARC-TRIG, ARC-VTE, ARC-CKD, ARC-T2D — include PRS and/or rare-variant and family-history integration.
We will provide a new kit at no charge. The analytical failure rate is under 5%.
Patient data and reports are stored in a HIPAA-compliant, encrypted environment.
Sign up with your NPI, state of license, and practice details.
Join the pilot program or reach out to our clinical team for a 30-minute walkthrough and sample report.